好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Gender disparities in deep brain stimulation surgery for Parkinson’s disease
Movement Disorders
P4 - Poster Session 4 (5:30 PM-6:30 PM)
1-007

To determine whether there is a gender disparity in access to deep brain stimulation surgery (DBS) for Parkinson’s disease (PD) at a large single health system, and to better understand the reasons for this discrepancy.

DBS is a safe and effective treatment in the management of advanced PD. Some studies have suggested that women are less likely to receive surgery compared to men despite similar post-surgical improvements. To improve access, it is important to understand the reasons for this disparity.

Data was taken from the University of Miami DBS Database, from January 2014 to December 2017. The sample included 3,251 PD patients (61.9% male). Data was analyzed using c2 and t-tests to examine group gender differences among the number of patients referred for surgery, reasons for referral, numbers receiving/not receiving surgery, reasons for not receiving surgery, and post-surgical outcomes.

Overall, 207 were referred for DBS (73.9% male), and 100 underwent surgery (77.0% male). Of the patients who did not receive surgery, the most common reasons were need for further medical optimization (26.2%), suboptimal performance on neuropsychological evaluation (22.4%), other reason (20.6%), lost to follow-up (18.7%), or patient preference (12.2%). Women were more likely to not receive surgery due to patient preference (30.0%, p= 0.005). Men were more likely to be lost to follow-up (p=0.032). There were no significant differences in post-surgical outcomes.

Despite similar post-surgical improvements, women were less likely to undergo deep brain stimulation surgery compared to men, frequently due to their own preference. These data underscore the need for increased education and community outreach in order to increase awareness and access to DBS, particularly for women, so that all PD patients who qualify for surgery can benefit from this procedure.  

Authors/Disclosures
Daniel Garbin Di Luca, MD (Washington University in St. Louis)
PRESENTER
Dr. Garbin Di Luca has nothing to disclose.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
No disclosure on file
Juan Sebastian Diaz, MD (University of Miami, Dept of Neurology) No disclosure on file
Jason H. Margolesky, MD, FAAN (University of Miami School of Medicine) Dr. Margolesky has nothing to disclose.
Henry P. Moore, MD (University of Miami - Miller School of Medicine) Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Bonnie E. Levin, PhD No disclosure on file
Carlos Singer, MD (University of Miami) Dr. Singer has nothing to disclose.
Jonathan Jagid Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Corneliu C. Luca, MD (University of Miami) Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.